SFRP4 and hydrops fetalis: Therefore, the identified small-molecule agents may reverse the over-expression levels of two hub genes (COL14A1, SFRP4) and two TFs (BNC2, MEOX2) in HF, thus inhibiting the regulatory network of TFs–hub genes–pathways and then alleviating HF progression.